What is QuaDPharma?
QuaDPharma Inc. is a notable entity operating within the Pharmaceuticals industry. The company, which employs between 10 to 19 individuals, generates revenue in the range of $10 million to $25 million. Its operations are centered on advancing pharmaceutical solutions, positioning it as a key player in its sector.
How much funding has QuaDPharma raised?
QuaDPharma has raised a total of $1.5M across 2 funding rounds:
Other Financing Round
$500K
Other Financing Round
$1M
Other Financing Round (2012): $500K with participation from Rand
Other Financing Round (2012): $1M led by Advantage Capital and Rand Capital SBIC , Inc.
Key Investors in QuaDPharma
Rand
RAND Corporation, founded in 1948, is a nonprofit research organization that develops solutions to public policy challenges. The company is headquartered in Santa Monica, California.
Advantage Capital
Advantage Capital Partners operates as a venture capital firm. The Company invests in cleantech, communication, energy, information technology, and life sciences industries. Advantage Capital Partners is located in New Orleans.
Rand Capital SBIC , Inc.
Undisclosed investor participating in the funding round.
What's next for QuaDPharma?
The substantial enterprise-level funding secured by QuaDPharma signals a pivotal growth phase. This capital injection is expected to fuel further research and development, potentially enabling market expansion and the scaling of its pharmaceutical offerings. The strategic nature of the recent investment suggests a focus on long-term value creation and market consolidation.
See full QuaDPharma company page
